MARKET

IXHL

IXHL

Incannex Healthcare Ltd
NASDAQ
0.4931
-0.0270
-5.19%
After Hours: 0.4950 +0.0018 +0.37% 16:05 04/07 EDT
OPEN
0.4900
PREV CLOSE
0.5201
HIGH
0.5231
LOW
0.4900
VOLUME
77.08K
TURNOVER
--
52 WEEK HIGH
3.550
52 WEEK LOW
0.4710
MARKET CAP
13.58M
P/E (TTM)
-0.3520
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IXHL last week (0331-0404)?
Weekly Report · 17h ago
Psychedelic: Enveric, Filament Health report earnings results
TipRanks · 4d ago
Incannex completes Phase 2 patient enrollment for RePOSA study of IHL-42X
TipRanks · 4d ago
Incannex Completes Phase 2 Enrollment for Sleep Apnea Drug Trial Targeting Better Rest
Benzinga · 4d ago
INCANNEX HEALTHCARE COMPLETES PHASE 2 ENROLLMENT IN REPOSA PHASE 2/3 TRIAL OF IHL-42X, AN ORAL ONCE-DAILY TREATMENT FOR OBSTRUCTIVE SLEEP APNEA (OSA)
Reuters · 4d ago
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
Barchart · 4d ago
Weekly Report: what happened at IXHL last week (0324-0328)?
Weekly Report · 03/31 09:58
Incannex files to sell 65.97M shares of common stock for holders
TipRanks · 03/25 19:22
More
About IXHL
More
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.
Recently
Symbol
Price
%Change

Webull offers Incannex Healthcare Inc stock information, including NASDAQ: IXHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IXHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IXHL stock methods without spending real money on the virtual paper trading platform.